160 related articles for article (PubMed ID: 24165045)
1. The significance of the alteration of 8-OHdG in serous ovarian carcinoma.
Xu X; Wang Y; Guo W; Zhou Y; Lv C; Chen X; Liu K
J Ovarian Res; 2013 Oct; 6(1):74. PubMed ID: 24165045
[TBL] [Abstract][Full Text] [Related]
2. Age is associated with prognosis in serous ovarian carcinoma.
Deng F; Xu X; Lv M; Ren B; Wang Y; Guo W; Feng J; Chen X
J Ovarian Res; 2017 Jun; 10(1):36. PubMed ID: 28606125
[TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis of follicle-stimulating hormone receptor in ovarian epithelial tumors: a novel approach to explain the field effect of ovarian cancer development in secondary mullerian systems.
Wang J; Lin L; Parkash V; Schwartz PE; Lauchlan SC; Zheng W
Int J Cancer; 2003 Jan; 103(3):328-34. PubMed ID: 12471615
[TBL] [Abstract][Full Text] [Related]
4. The anterior gradient homolog 3 (AGR3) gene is associated with differentiation and survival in ovarian cancer.
King ER; Tung CS; Tsang YT; Zu Z; Lok GT; Deavers MT; Malpica A; Wolf JK; Lu KH; Birrer MJ; Mok SC; Gershenson DM; Wong KK
Am J Surg Pathol; 2011 Jun; 35(6):904-12. PubMed ID: 21451362
[TBL] [Abstract][Full Text] [Related]
5. Nadir CA-125 level as prognosis indicator of high-grade serous ovarian cancer.
Xu X; Wang Y; Wang F; Jia L; Zhou Y; Deng F; Qu J; Zhou B; Meng A; Fu B; Chen X; Qian Z; Wang J
J Ovarian Res; 2013; 6():31. PubMed ID: 23618037
[TBL] [Abstract][Full Text] [Related]
6. Ascites regression following neoadjuvant chemotherapy in prediction of treatment outcome among stage IIIc to IV high-grade serous ovarian cancer.
Xu X; Deng F; Lv M; Ren B; Guo W; Chen X
J Ovarian Res; 2016 Dec; 9(1):85. PubMed ID: 27912779
[TBL] [Abstract][Full Text] [Related]
7. Analysis of DNA copy number alterations in ovarian serous tumors identifies new molecular genetic changes in low-grade and high-grade carcinomas.
Kuo KT; Guan B; Feng Y; Mao TL; Chen X; Jinawath N; Wang Y; Kurman RJ; Shih IeM; Wang TL
Cancer Res; 2009 May; 69(9):4036-42. PubMed ID: 19383911
[TBL] [Abstract][Full Text] [Related]
8. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
[No Abstract] [Full Text] [Related]
9. [Expression and promotor methylation of p73 gene in ovarian epithelial tumors].
Zhang YL; Guo XR; Shen DH; Cheng YX; Liang XD; Chen YX; Wang Y
Zhonghua Bing Li Xue Za Zhi; 2012 Jan; 41(1):33-8. PubMed ID: 22455848
[TBL] [Abstract][Full Text] [Related]
10. Nicotinamide N-methyltransferase overexpression may be associated with poor prognosis in ovarian cancer.
Harmankaya İ; Akar S; Uğraş S; Güler AH; Ezveci H; Aydoğdu M; Çelik Ç
J Obstet Gynaecol; 2021 Feb; 41(2):248-253. PubMed ID: 32285726
[TBL] [Abstract][Full Text] [Related]
11. Poly(adenosine diphosphate-ribose) polymerase expression in serous ovarian carcinoma: correlation with p53, MIB-1, and outcome.
Brustmann H
Int J Gynecol Pathol; 2007 Apr; 26(2):147-53. PubMed ID: 17413981
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of the hOGG1 gene and high 8-hydroxy-2'-deoxyguanosine (8-OHdG) lyase activity in human colorectal carcinoma: regulation mechanism of the 8-OHdG level in DNA.
Kondo S; Toyokuni S; Tanaka T; Hiai H; Onodera H; Kasai H; Imamura M
Clin Cancer Res; 2000 Apr; 6(4):1394-400. PubMed ID: 10778969
[TBL] [Abstract][Full Text] [Related]
13. Reactive Oxygen Species and Serous Epithelial Ovarian Adenocarcinoma.
Cohen S; Mehrabi S; Yao X; Millingen S; Aikhionbare FO
Cancer Res J (N Y N Y); 2016 Nov; 4(6):106-114. PubMed ID: 28503633
[TBL] [Abstract][Full Text] [Related]
14. MiR-182 overexpression in tumourigenesis of high-grade serous ovarian carcinoma.
Liu Z; Liu J; Segura MF; Shao C; Lee P; Gong Y; Hernando E; Wei JJ
J Pathol; 2012 Oct; 228(2):204-15. PubMed ID: 22322863
[TBL] [Abstract][Full Text] [Related]
15. [Expression and clinical relevance of ARHI, STAT3 and E2F1 in ovarian serous carcinoma].
Zhang J; Li YH; Cui AR; Wang JL; Cheng JX; Wang SJ
Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):905-9. PubMed ID: 19173990
[TBL] [Abstract][Full Text] [Related]
16. Oxidative DNA damage in pterygium.
Tsai YY; Cheng YW; Lee H; Tsai FJ; Tseng SH; Lin CL; Chang KC
Mol Vis; 2005 Jan; 11():71-5. PubMed ID: 15692461
[TBL] [Abstract][Full Text] [Related]
17. Secretoglobin expression in ovarian carcinoma: lipophilin B gene upregulation as an independent marker of better prognosis.
Bignotti E; Tassi RA; Calza S; Ravaggi A; Rossi E; Donzelli C; Todeschini P; Romani C; Bandiera E; Zanotti L; Carnazza M; Quadraro F; Tognon G; Sartori E; Pecorelli S; Roque DM; Santin AD
J Transl Med; 2013 Jul; 11():162. PubMed ID: 23819652
[TBL] [Abstract][Full Text] [Related]
18. Preoperative serum 8-hydroxydeoxyguanosine is associated with chemoresistance and is a powerful prognostic factor in endometrioid-type epithelial ovarian cancer.
Pylväs-Eerola M; Karihtala P; Puistola U
BMC Cancer; 2015 Jul; 15():493. PubMed ID: 26134400
[TBL] [Abstract][Full Text] [Related]
19. Identification of glia maturation factor beta as an independent prognostic predictor for serous ovarian cancer.
Li YL; Ye F; Cheng XD; Hu Y; Zhou CY; Lü WG; Xie X
Eur J Cancer; 2010 Jul; 46(11):2104-18. PubMed ID: 20547056
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of transcriptome reveals let-7b as an unfavorable prognostic biomarker and predicts molecular and clinical subclasses in high-grade serous ovarian carcinoma.
Tang Z; Ow GS; Thiery JP; Ivshina AV; Kuznetsov VA
Int J Cancer; 2014 Jan; 134(2):306-18. PubMed ID: 23825028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
